Behavioral Health Business June 14, 2024
Chris Larson

The Drug Enforcement Administration is preparing to release its final rule for telehealth and controlled substances.

On Thursday, the White House’s Office of Management and Budget (OMB) received the final rule from the DEA. The OMB oversees the coordination and review of major executive branch actions. It’s the final stop before the final rules are published.

The rule itself has not been released. It’s unclear when that will happen.

The release of the final rule would present the next evolution in establishing a post-COVID paradigm for the use of telehealth in prescribing controlled substances.

In March 2023, the DEA published two interrelated rules. They re-established rules that require controlled substances categorized under the DEA’s Schedule II through V to be...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Govt Agencies, Mental Health, Provider, Technology, Telehealth
The Doctor Will See You… On Amazon: Tech Giant Expands Plans to Merge Medicine with Marketplace
There’s a new game in town for D2C health business models
Telehealth Companies Boost Ad Spending While Taking on More Complex Medicine
Telehealth Partnerships: A Value-Added Service for Providers
The technology redefining healthcare as borderless and inclusive

Share This Article